Article
Targeting oncogenic TERT promoter variants by allele-specific epigenome editing.
Clinical epigenetics - 22 Nov 2023
Kouroukli Alexandra G, Rajaram Nivethika, Bashtrykov Pavel, Kretzmer Helene, Siebert Reiner, Jeltsch Albert, Bens Susanne
Abstract excerpt
BACKGROUND: Activation of dominant oncogenes by small or structural genomic alterations is a common driver mechanism in many cancers. Silencing of such dominantly activated oncogenic alleles, thus, is a promising strategy to treat cancer. Recently, allele-specific epigenome editing (ASEE) has been described as a means to reduce transcription of genes in an allele-specific manner. In cancer, specificity to an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
